Skip to main content
Top

26-04-2024 | Craniopharyngioma | Original article

Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma

Authors: Ying Feng, Liyong Zhong

Published in: Acta Neurologica Belgica

Login to get access

Abstract

Craniopharyngioma (CP), a rare benign intracranial tumor, is still a major clinical challenge. There are two major histologic phenotypes: papillary CP (PCP) and adamantinomatous CP (ACP). This research aimed to assess the occurrence of central diabetes insipidus (antidiuretic hormone deficiency), the level of prolactin, and the stalk effect between PCP and ACP subtypes prior to and after surgery. Clinical data of CP patients before and after surgical resection of the tumor were analyzed retrospectively. These patients were divided into PCP and ACP groups, in accordance with the pathologic classification. The data of prolactin level, 24-h urinary volume, urine specific gravity and electrolyte status before and after surgery were evaluated in these two CP subtypes. A total of 86 CP patients were included, among which 28 patients were PCP and 58 were ACP. Compared to those prior to surgery, 24-h urine volume, serum sodium and serum chlorine concentrations were obviously increased, while prolactin and urine specific gravity were remarkably decreased in all the CP patients after surgery. Compared to those before operation, prolactin level and urine specific gravity were decreased, and 24-h urine volume, serum sodium and serum chlorine were elevated after operation in ACP patients. Moreover, after surgery, 24-h urine volume in PCP patients was higher than that in ACP group. The central diabetes insipidus in patients with CP was aggravated after surgical resection, especially in ACP patients. Moreover, the central diabetes insipidus of PCP subtype was more serious than that of ACP subtype.
Literature
1.
go back to reference Otte A, Muller HL (2021) Childhood-onset craniopharyngioma. J Clin Endocrinol Metab 106:e3820–e3836CrossRefPubMed Otte A, Muller HL (2021) Childhood-onset craniopharyngioma. J Clin Endocrinol Metab 106:e3820–e3836CrossRefPubMed
2.
go back to reference Prieto R, Rosdolsky M, Hofecker V, Barrios L, Pascual JM (2020) Craniopharyngioma treatment: an updated summary of important clinicopathological concepts. Expert Rev Endocrinol Metab 15:261–282CrossRefPubMed Prieto R, Rosdolsky M, Hofecker V, Barrios L, Pascual JM (2020) Craniopharyngioma treatment: an updated summary of important clinicopathological concepts. Expert Rev Endocrinol Metab 15:261–282CrossRefPubMed
3.
go back to reference Muller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5:75CrossRefPubMed Muller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5:75CrossRefPubMed
4.
go back to reference Muller HL (2020) The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110:753–766CrossRefPubMed Muller HL (2020) The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110:753–766CrossRefPubMed
5.
go back to reference Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44:518–538CrossRefPubMed Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44:518–538CrossRefPubMed
6.
go back to reference Iglesias P (2022) Targeted therapies in the medical management of craniopharyngioma. Pituitary 25:383–392CrossRefPubMed Iglesias P (2022) Targeted therapies in the medical management of craniopharyngioma. Pituitary 25:383–392CrossRefPubMed
7.
go back to reference Martinez-Barbera JP, Andoniadou CL (2020) Biological behaviour of craniopharyngiomas. Neuroendocrinology 110:797–804CrossRefPubMed Martinez-Barbera JP, Andoniadou CL (2020) Biological behaviour of craniopharyngiomas. Neuroendocrinology 110:797–804CrossRefPubMed
8.
go back to reference Erfurth EM (2020) Diagnosis, background, and treatment of hypothalamic damage in craniopharyngioma. Neuroendocrinology 110:767–779CrossRefPubMed Erfurth EM (2020) Diagnosis, background, and treatment of hypothalamic damage in craniopharyngioma. Neuroendocrinology 110:767–779CrossRefPubMed
9.
go back to reference Guo Y, Pei L, Li Y, Li C, Gui S, Ni M, Liu P, Zhang Y, Zhong L (2023) Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Front Endocrinol (Lausanne) 14:1180591CrossRefPubMed Guo Y, Pei L, Li Y, Li C, Gui S, Ni M, Liu P, Zhang Y, Zhong L (2023) Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Front Endocrinol (Lausanne) 14:1180591CrossRefPubMed
10.
go back to reference Feldt-Rasmussen U, Effraimidis G, Klose M (2021) The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol Cell Endocrinol 525:111173CrossRefPubMed Feldt-Rasmussen U, Effraimidis G, Klose M (2021) The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions. Mol Cell Endocrinol 525:111173CrossRefPubMed
11.
go back to reference Ni Y, Chen Q, Cai J, Xiao L, Zhang J (2021) Three lactation-related hormones: regulation of hypothalamus-pituitary axis and function on lactation. Mol Cell Endocrinol 520:111084CrossRefPubMed Ni Y, Chen Q, Cai J, Xiao L, Zhang J (2021) Three lactation-related hormones: regulation of hypothalamus-pituitary axis and function on lactation. Mol Cell Endocrinol 520:111084CrossRefPubMed
12.
go back to reference Bergsneider M, Mirsadraei L, Yong WH, Salamon N, Linetsky M, Wang MB, McArthur DL, Heaney AP (2014) The pituitary stalk effect: is it a passing phenomenon? J Neurooncol 117:477–484CrossRefPubMed Bergsneider M, Mirsadraei L, Yong WH, Salamon N, Linetsky M, Wang MB, McArthur DL, Heaney AP (2014) The pituitary stalk effect: is it a passing phenomenon? J Neurooncol 117:477–484CrossRefPubMed
13.
go back to reference Edate S, Albanese A (2015) Management of electrolyte and fluid disorders after brain surgery for pituitary/suprasellar tumours. Horm Res Paediatr 83:293–301CrossRefPubMed Edate S, Albanese A (2015) Management of electrolyte and fluid disorders after brain surgery for pituitary/suprasellar tumours. Horm Res Paediatr 83:293–301CrossRefPubMed
14.
go back to reference Badmaeva IN, Astafieva LI, Kalinin PL, Kadashev BA, Kutin MA (2021) Central diabetes insipidus after resection of sellar-suprasellar tumors: prevalence and predictors of manifestation. Zh Vopr Neirokhir Im N N Burdenko 85:111–118CrossRefPubMed Badmaeva IN, Astafieva LI, Kalinin PL, Kadashev BA, Kutin MA (2021) Central diabetes insipidus after resection of sellar-suprasellar tumors: prevalence and predictors of manifestation. Zh Vopr Neirokhir Im N N Burdenko 85:111–118CrossRefPubMed
15.
go back to reference Gorelyshev S, Savateev AN, Mazerkina N, Medvedeva O, Konovalov AN (2022) Craniopharyngiomas: surgery and radiotherapy. Adv Tech Stand Neurosurg 45:97–137CrossRefPubMed Gorelyshev S, Savateev AN, Mazerkina N, Medvedeva O, Konovalov AN (2022) Craniopharyngiomas: surgery and radiotherapy. Adv Tech Stand Neurosurg 45:97–137CrossRefPubMed
16.
go back to reference Kadashev BA, Konovalov AN, Astaf’eva LI, Kalinin PL, Kutin MA, Klochkova IS, Fomichev DV, Sharipov OI, Andreev DN (2018) Preoperative and postoperative endocrine disorders associated with pituitary stalk injuries caused by suprasellar growing tumors. Zh Vopr Neirokhir Im N N Burdenko 82:13–21CrossRefPubMed Kadashev BA, Konovalov AN, Astaf’eva LI, Kalinin PL, Kutin MA, Klochkova IS, Fomichev DV, Sharipov OI, Andreev DN (2018) Preoperative and postoperative endocrine disorders associated with pituitary stalk injuries caused by suprasellar growing tumors. Zh Vopr Neirokhir Im N N Burdenko 82:13–21CrossRefPubMed
17.
go back to reference Angelousi A, Alexandraki KI, Mytareli C, Grossman AB, Kaltsas G (2023) New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance). J Neuroendocrinol 35:e13233CrossRefPubMed Angelousi A, Alexandraki KI, Mytareli C, Grossman AB, Kaltsas G (2023) New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance). J Neuroendocrinol 35:e13233CrossRefPubMed
18.
go back to reference Korkmaz HA, Kapoor RR, Kalitsi J, Aylwin SJ, Buchanan CR, Arya VB (2022) Central diabetes insipidus in children and adolescents: twenty-six year experience from a single centre. Int J Endocrinol 2022:9397130CrossRefPubMedPubMedCentral Korkmaz HA, Kapoor RR, Kalitsi J, Aylwin SJ, Buchanan CR, Arya VB (2022) Central diabetes insipidus in children and adolescents: twenty-six year experience from a single centre. Int J Endocrinol 2022:9397130CrossRefPubMedPubMedCentral
19.
go back to reference Jameel PZ, Lohiya S, Vagha K, Ahmed T, Pujari D, Vagha J, Varma A (2021) Concurrent central diabetes insipidus and cerebral salt wasting disease in a post-operative case of craniopharyngioma: a case report. BMC Pediatr 21:502CrossRefPubMedPubMedCentral Jameel PZ, Lohiya S, Vagha K, Ahmed T, Pujari D, Vagha J, Varma A (2021) Concurrent central diabetes insipidus and cerebral salt wasting disease in a post-operative case of craniopharyngioma: a case report. BMC Pediatr 21:502CrossRefPubMedPubMedCentral
20.
go back to reference Gupta S, Bi WL, Giantini Larsen A, Al-Abdulmohsen S, Abedalthagafi M, Dunn IF (2018) Craniopharyngioma: a roadmap for scientific translation. Neurosurg Focus 44:E12CrossRefPubMed Gupta S, Bi WL, Giantini Larsen A, Al-Abdulmohsen S, Abedalthagafi M, Dunn IF (2018) Craniopharyngioma: a roadmap for scientific translation. Neurosurg Focus 44:E12CrossRefPubMed
22.
go back to reference Campanini ML, Almeida JP, Martins CS, de Castro M (2023) The molecular pathogenesis of craniopharyngiomas. Arch Endocrinol Metab 67:266–275PubMedPubMedCentral Campanini ML, Almeida JP, Martins CS, de Castro M (2023) The molecular pathogenesis of craniopharyngiomas. Arch Endocrinol Metab 67:266–275PubMedPubMedCentral
23.
go back to reference Qin C, Hu W, Wang X, Ma X (2021) Application of artificial intelligence in diagnosis of craniopharyngioma. Front Neurol 12:752119CrossRefPubMed Qin C, Hu W, Wang X, Ma X (2021) Application of artificial intelligence in diagnosis of craniopharyngioma. Front Neurol 12:752119CrossRefPubMed
25.
go back to reference Wu J, Wu X, Yang YQ, Ding H, Yang L, Bao YY, Zhou L, Yang CX, Hong T (2022) Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis. Neurosurg Rev 45:139–150CrossRefPubMed Wu J, Wu X, Yang YQ, Ding H, Yang L, Bao YY, Zhou L, Yang CX, Hong T (2022) Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis. Neurosurg Rev 45:139–150CrossRefPubMed
26.
go back to reference Sun F, Sun X, Du X, Xing H, Yang B (2017) Factors related to endocrine changes and hormone substitution treatment during pre- and post-operation stages in craniopharyngioma. Oncol Lett 13:250–252CrossRefPubMed Sun F, Sun X, Du X, Xing H, Yang B (2017) Factors related to endocrine changes and hormone substitution treatment during pre- and post-operation stages in craniopharyngioma. Oncol Lett 13:250–252CrossRefPubMed
27.
go back to reference Dho YS, Kim YH, Se YB, Han DH, Kim JH, Park CK, Wang KC, Kim DG (2018) Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor. J Neurosurg 129:611–619CrossRefPubMed Dho YS, Kim YH, Se YB, Han DH, Kim JH, Park CK, Wang KC, Kim DG (2018) Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor. J Neurosurg 129:611–619CrossRefPubMed
28.
go back to reference Cheng J, Fan Y, Cen B (2017) Effect of preserving the pituitary stalk during resection of craniopharyngioma in children on the diabetes insipidus and relapse rates and long-term outcomes. J Craniofac Surg 28:e591–e595CrossRefPubMed Cheng J, Fan Y, Cen B (2017) Effect of preserving the pituitary stalk during resection of craniopharyngioma in children on the diabetes insipidus and relapse rates and long-term outcomes. J Craniofac Surg 28:e591–e595CrossRefPubMed
29.
go back to reference Huang K, Zhou L, Chen Y, Liu C, Zhao L, Liu Y, Liu P (2023) Effect of preserving the pituitary stalk during resection of craniopharyngioma: a case series. Asian J Surg 46:1639–1640CrossRefPubMed Huang K, Zhou L, Chen Y, Liu C, Zhao L, Liu Y, Liu P (2023) Effect of preserving the pituitary stalk during resection of craniopharyngioma: a case series. Asian J Surg 46:1639–1640CrossRefPubMed
30.
go back to reference Chen Y, Hu F, Wang J, Huang K, Liu W, Tan Y, Zhao K, Xiao Q, Lei T, Shu K (2022) Clinical features of craniopharyngioma with tumoral hemorrhage: a retrospective case-controlled study. Front Surg 9:845273CrossRefPubMedPubMedCentral Chen Y, Hu F, Wang J, Huang K, Liu W, Tan Y, Zhao K, Xiao Q, Lei T, Shu K (2022) Clinical features of craniopharyngioma with tumoral hemorrhage: a retrospective case-controlled study. Front Surg 9:845273CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma
Authors
Ying Feng
Liyong Zhong
Publication date
26-04-2024
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-024-02558-1